Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‑1α signaling
Molecular Medicine Reports · 2024
DOI: 10.3892/mmr.2024.13383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, 2024. Verfasst von Zhongyou Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, Zhumadian Hospital of Traditional Chinese Medicine, Zhumadian, Henan 463000, P.R. China. Hauptthemen laut MEDLINE: Flavanones, Acute Lung Injury, Hypoxia-Inducible Factor 1, alpha Subunit, Glycolysis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Baicalein, a flavonoid monomer compound isolated from the dried root of the traditional Chinese herb Scutellaria baicalensis, has several pharmacological activities, such as anti‑inflammatory, anti‑angiogenic, antitumor, antimicrobial and antiviral properties. Acute lung injury (ALI) is characterized by injury of the alveolar epithelium and capillary endothelium, which results in decreased lung volume, decreased lung compliance, ventilation/perfusion mismatch, intrapulmonary edema, alveolar edema and even acute hypoxemic respiratory failure. The present study aimed to investigate the effects of baicalein on lung injury and inflammation. Bioinformatics analysis using network pharmacology predicted that the hypoxia inducible factor‑1α (HIF‑1α) and glycolysis signaling pathways were involved in the mechanism underlying the therapeutic effects of baicalein. Further in vitro and in vivo experiments, such as immunohistochemistry, immunofluorescence and PCR, verified that baicalein could inhibit HIF‑1α signaling, thus suppressing glycolysis, and improving inflammatory responses and ALI. Taken together, the results of the present study suggested that the anti‑inflammatory effects of baicalein on treating ALI were associated with its ability to suppress glycolysis via the HIF‑1α signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Diseases, Zhumadian Hospital of Traditional Chinese Medicine, Zhumadian, Henan 463000, P.R. China.
- Department of Scientific Research, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450046, P.R. China.
- Department of Respiratory Diseases, Zhengzhou Hospital of Traditional Chinese Medicine, Zhengzhou, Henan 450007, P.R. China.
Zitieren
APA
Liu, Z., Zheng, X., Li, N., & Wang, Z. (2024). Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‑1α signaling. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2024.13383
Vancouver
Liu Z, Zheng X, Li N, Wang Z. Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‑1α signaling. Molecular Medicine Reports. 2024. doi:10.3892/mmr.2024.13383
BibTeX
@article{Liu2024,
author = {Liu, Zhongyou and Zheng, Xiaona and Li, Ning and Wang, Zongyao},
title = {Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‑1α signaling},
journal = {Molecular Medicine Reports},
year = {2024},
doi = {10.3892/mmr.2024.13383}
}
EUVIMED